[go: up one dir, main page]

IL130808A0 - Antibodies that bind to the nidogen-binding domain of laminin their production and use - Google Patents

Antibodies that bind to the nidogen-binding domain of laminin their production and use

Info

Publication number
IL130808A0
IL130808A0 IL13080897A IL13080897A IL130808A0 IL 130808 A0 IL130808 A0 IL 130808A0 IL 13080897 A IL13080897 A IL 13080897A IL 13080897 A IL13080897 A IL 13080897A IL 130808 A0 IL130808 A0 IL 130808A0
Authority
IL
Israel
Prior art keywords
nidogen
laminin
antibodies
bind
production
Prior art date
Application number
IL13080897A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL130808A0 publication Critical patent/IL130808A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL13080897A 1997-01-17 1997-12-22 Antibodies that bind to the nidogen-binding domain of laminin their production and use IL130808A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701607A DE19701607A1 (de) 1997-01-17 1997-01-17 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung
PCT/EP1997/007241 WO1998031709A1 (de) 1997-01-17 1997-12-22 Antikörper, die an die nidogen-bindungsdomäne des laminins binden, deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
IL130808A0 true IL130808A0 (en) 2001-01-28

Family

ID=7817701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13080897A IL130808A0 (en) 1997-01-17 1997-12-22 Antibodies that bind to the nidogen-binding domain of laminin their production and use

Country Status (18)

Country Link
US (1) US20010007020A1 (de)
EP (1) EP0954535A1 (de)
JP (1) JP2001509020A (de)
KR (1) KR20000070256A (de)
CN (1) CN1244873A (de)
AR (1) AR011074A1 (de)
AU (1) AU5985398A (de)
BR (1) BR9714207A (de)
CA (1) CA2278477A1 (de)
CZ (1) CZ253899A3 (de)
DE (1) DE19701607A1 (de)
HU (1) HUP0001808A3 (de)
ID (1) ID21895A (de)
IL (1) IL130808A0 (de)
PL (1) PL334956A1 (de)
TR (1) TR199901648T2 (de)
WO (1) WO1998031709A1 (de)
ZA (1) ZA98367B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087318A1 (en) * 1994-04-18 2003-05-08 Lallone Roger L. Antibodies against an extracellular matrix complex and their use in the detection of cancer
EP1070727A1 (de) 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Niedermolekulare Peptide als Inhibitoren der Laminin/Nidogen Wechselwirkung
AU784338B2 (en) * 1999-11-01 2006-03-16 Curagen Corporation Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
WO2001061349A1 (en) * 2000-02-18 2001-08-23 The University Of Tennessee Research Corporation Detection of microbial deposition and immune response at the basement membrane
EP1268783B9 (de) * 2000-03-29 2007-01-17 Beth Israel Deaconess Medical Center, Inc. Anti-angiogenic properties of matin and of fragments or variants thereof
US20030119739A1 (en) * 2000-03-29 2003-06-26 Beth Israel Deaconess Medical Center Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
WO2004093892A2 (en) 2003-04-16 2004-11-04 Genentech, Inc. Stanniocalcin-1, variant or antagonists thereof for selective modulation of vascularization
US20140045196A1 (en) * 2012-08-13 2014-02-13 University Of Tokyo Methods of prognosis and diagnosis of cancer
CN110860766A (zh) * 2019-10-22 2020-03-06 广东开放大学（广东理工职业学院） 铝合金薄板的调制脉冲电流焊接方法、系统及存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211657A (en) * 1988-11-07 1993-05-18 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
DE59511090D1 (de) * 1994-08-11 2008-05-08 Sanofi Aventis Deutschland Monoklonale Antikörper zur selektiven immunologischen Bestimmung von hochmolekularen, intakten Lamininformen in Körperflüssigkeiten
US5493008A (en) * 1994-08-15 1996-02-20 The University Of Virginia Patent Foundation Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain

Also Published As

Publication number Publication date
HUP0001808A2 (hu) 2000-09-28
CZ253899A3 (cs) 1999-10-13
AU5985398A (en) 1998-08-07
DE19701607A1 (de) 1998-07-23
KR20000070256A (ko) 2000-11-25
ZA98367B (en) 1998-07-17
CA2278477A1 (en) 1998-07-23
US20010007020A1 (en) 2001-07-05
AR011074A1 (es) 2000-08-02
BR9714207A (pt) 2000-03-28
JP2001509020A (ja) 2001-07-10
CN1244873A (zh) 2000-02-16
HUP0001808A3 (en) 2001-09-28
PL334956A1 (en) 2000-03-27
EP0954535A1 (de) 1999-11-10
ID21895A (id) 1999-08-05
TR199901648T2 (xx) 1999-10-21
WO1998031709A1 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
HUP1500179A2 (en) The use of human tnf-alpha binding antibodies
IL112529A0 (en) Peptides and compounds that bind to the IL-1 receptor
EG21397A (en) Improved in the production of spun-bonded web
ID26590A (id) Komposisi-komposisi dua fasa bebas pewangi dan metode-metode untuk menurunkan bau badan dan lingkungan
HUP9900239A3 (en) Modified avidin and streptavidin molecules and use thereof
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
NO20003394D0 (no) FremgangsmÕte for fremstilling av syntetiske silikater og anvendelse derav i glassproduksjon
ID19878A (id) Kemasan untuk tumpukan lembaran dan proses pembuatannya
AU4972096A (en) Peptides and compounds that bind to sh2 domains
AU6949800A (en) Compositions and methods for the treatment of sepsis using antibodies to c5a
EP0804339A4 (de) Dekoratives baumaterial und verfahren zu dessen herstellung
HUP0101151A3 (en) Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbetha6-integrin attachment to fibnronectin
IL130808A0 (en) Antibodies that bind to the nidogen-binding domain of laminin their production and use
SG73392A1 (en) Improvement of the dynamic range in specific binding assays
GB9615682D0 (en) The process of asphalt purification and the composition of modified asphalt
AU6560196A (en) Cytohesin-PH peptides that affect the ability of integrins to adhere
GB9701878D0 (en) Improvements relating to the formation of pipes and pipelines
GB9606425D0 (en) Improvements in and relating to the production of antibodies and test kits incorporating antibodies
FI964854A7 (fi) Hydroksitioasetamidien valmistus ja niiden käyttö bentsotiofeenien syn teesissä
EP0934063A4 (de) Verwendung von hyalorunan in gentherapie
EP1070081A4 (de) Neue moleküle der t129-ähnlichen proteinfamilie und ihre anwendung
KR970020692U (ko) 분해결합이 가능한 넵킨통의 구조
GB9708932D0 (en) Improvements in and relating to the manufacture of snack products
DK0852555T3 (da) Beholderlegeme med to skuldre
GB9602308D0 (en) Improvements relating to the formation of pipes and pipelines